SCHEMBL1013814

SCHEMBL1013814

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cc(-c2ccccc2OC)ccc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 5/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 4/20 0.49
MAPT P10636 4/20 0.46
GBA1 P04062 1/20 0.46
THRB P10828 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
DHODH Q02127 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012800 0.92 KDM4E (0.59) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1014695 0.85 ALDH1A1 (0.53) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1015634 0.85 ALDH1A1 (0.53) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1016584 0.85 ALDH1A1 (0.50) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1013557 0.84 ALDH1A1 (0.54) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1015922 0.82 PPARG (0.51) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1015866 0.82 ALDH1A1 (0.51) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL418470 0.82 SMN1; SMN2 (0.57) GAASMN1; SMN2ALDH1A1LMNAKDM4E
SCHEMBL1015997 0.81 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1LMNAKDM4EMAPT
SCHEMBL1015109 0.81 SERPINE1 (0.57) SMN1; SMN2ALDH1A1LMNAKDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 GAA 459/4885SMN1; SMN2 2290/4885ALDH1A1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.